Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 1.00 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 1.00 |
| ▸ | LDHB | P07195 | 3/20 | 0.43 |
| ▸ | TERF2IP | Q9NYB0 | 4/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.39 |
| ▸ | NPY2R | P49146 | 1/20 | 0.39 |
| ▸ | NPY4R | P50391 | 1/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.39 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.39 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.39 |
| ▸ | SSTR5 | P35346 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27013344 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL136097 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL18902502 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL14241069 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL16549195 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL23626629 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL19532503 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL15507051 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL21991628 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| Polymyxin B2 SCHEMBL29514784 | 0.99 | KDM1A (0.98) | KDM1ARCOR1LDHBTERF2IPEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027191-A1 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE | UNIV ARIZONA (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4628100-A2 | ANTI-VIRAL COMPOUNDS AND METHODS FOR ADMINISTRATION THEREOF | Gregg, John Malcolm Hall (US) | 2025-10-08 | — | — | EP | disclosed |
| US-12285413-B2 | Anti-viral agents and methods for administration thereof | GREGG JOHN M H (US) | 2025-04-29 | — | — | US | disclosed |
| WO-2025074091-A1 | POLYPEPTIDES AND PEPTIDE TAGS CAPABLE OF SPONTANEOUS ISOPEPTIDE BOND FORMATION AT LOW TEMPERATURE AND LOW PH AND USES THEREOF | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2025-04-10 | — | — | WO | disclosed |
| US-20250099566-A1 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE | NATIONAL INSTITUTES OF HEALTH | 2025-03-27 | — | — | US | disclosed |
| US-20240173456-A1 | THERAPEUTIC COMPOSITIONS FOR WOUND TREATMENT | ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY | 2024-05-30 | — | — | US | disclosed |
| CN-117447619-A | Polygonatum polysaccharide composition for treating ulcerative colitis and preparation method of polysaccharide composition | 捷通国际有限公司 | 2024-01-26 | — | — | CN | disclosed |
| WO-2023201345-A2 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2023-10-19 | — | — | WO | disclosed |
| US-20230263778-A1 | ANTI-VIRAL COMPOUNDS AND METHODS FOR ADMINISTRATION THEREOF | GREGG JOHN M H (US) | 2023-08-24 | — | — | US | disclosed |
| US-11732286-B2 | T5 exonuclease-based method to identify DNA topoisomerase inhibitors | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-08-22 | — | — | US | disclosed |
| US-20140171358-A1 | ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA AND NEOMYCIN SULFATE AND METHODS OF USE THEREOF | DIGNITY SCIENCES LIMITED (IE) | 2014-06-19 | — | — | US | disclosed |
| US-20130289139-A1 | DIAGNOSTIC ASSAY | CELLESTIS INTERNATIONAL PTY LTD. (AU) | 2013-10-31 | — | — | US | disclosed |
| US-8343912-B2 | Antibiotic compositions for the treatment of gram negative infections | BIOSOURCE PHARM, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-8343912-B2 | Antibiotic compositions for the treatment of gram negative infections | BIOSOURCE PHARM, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-20120264705-A1 | ANTIMICROBIAL COMPOSITIONS COMPRISING 15-HETRE AND METHODS OF USE THEREOF | DIGNITY SCIENCES LIMITED (IE) | 2012-10-18 | — | — | US | disclosed |
| US-20100160215-A1 | ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OF GRAM NEGATIVE INFECTIONS | BIOSOURCE PHARM, INC. | 2010-06-24 | — | — | US | disclosed |
| US-20100160215-A1 | ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OF GRAM NEGATIVE INFECTIONS | BIOSOURCE PHARM, INC. | 2010-06-24 | — | — | US | disclosed |
| US-20090280069-A1 | PROGUANIL TO TREAT SKIN/MUCOSAL DISEASES | TOLMAR, INC. (US) | 2009-11-12 | — | — | US | disclosed |
| US-20090280069-A1 | PROGUANIL TO TREAT SKIN/MUCOSAL DISEASES | TOLMAR, INC. (US) | 2009-11-12 | — | — | US | disclosed |
| US-5120711-A | Of polymyxin B and chlorquinaldol; for treatment of mastitis or fungal infections | EGIS GYOGYSZERGYAR (HU) | 1992-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090280069-A1 | PROGUANIL TO TREAT SKIN/MUCOSAL DISEASES | PROKR1, PROKR2, MC1R | KDM1A 4182/4885RCOR1 1670/4885LDHB 3544/4885 |
| US-20230263778-A1 | ANTI-VIRAL COMPOUNDS AND METHODS FOR ADMINISTRATION THEREOF | ACE2, ACE, SARS1 | KDM1A 4708/4885RCOR1 4044/4885LDHB 147/4885 |
| US-20260027191-A1 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE | DNMT3L, DNMT3A, DNMT1 | KDM1A 548/4885RCOR1 4343/4885LDHB 3153/4885 |
| US-12285413-B2 | Anti-viral agents and methods for administration thereof | ACE2, ACE, MAVS | KDM1A 4539/4885RCOR1 3100/4885LDHB 320/4885 |
| US-20100160215-A1 | ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OF GRAM NEGATIVE INFECTIONS | PSMB7, IL17A, IL1B | KDM1A 4264/4885RCOR1 4799/4885LDHB 1383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.